Clinical presentations of polycystic ovary syndrome in a tertiary care centre of southern Rajasthan, India
Abstract
Background: Polycystic ovarian syndrome (PCOS) is a reproductive-endocrine-metabolic disorder that involves multiple medical specialities. It can affect the entire lifespan of a woman. This disorder often strikes young girls at the time when they are stepping into the newer horizon of youth. Considering the symptoms of PCOS such as obesity, infertility, hirsutism, baldness etc., PCOS can be termed as “Silent Killer” of a woman’s womanhood.
Material and Methods: This observational study was carried out from Jan. 2016 to Sept. 2019 in Ananta Institute of Medical Sciences and Research Centre. A total of 100 newly diagnosed post-pubertal PCOS patients consulting gynaecology and dermatology department were studied. Statistical analysis was carried out by the Chi-square test and independent samples t-test. Statistical significance was determined at a level of P< 0.05.
Results: Authors concluded that PCOS can occur in both obese and non-obese women with high prevalence of cutaneous manifestations.
Conclusion: PCOS is a public health issue of great concern and is well said to be a hidden epidemic. It represents an Iceberg with multiple tips and widening base. The dermatologic manifestations of PCOS play a significant role in diagnosis. Success in the effective management of women with PCOS is through a trans-disciplinary integrative and synchronized clinical care by the gynecologist, endocrinologist, dermatologist, nutritionist, and physical trainer.
Downloads
References
2. Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, et al. Quality of life, psychosocial wellbeing, and sexual satisfaction in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2003; 88(12):5801-5807. doi: https://doi.org/10.1210/jc.2003-030562.
3. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935; 29(2):181-191. doi: https://doi.org/10.1016/S0002-9378(15)30642-6.
4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774-800. doi: https://doi.org/10.1210/edrv.18.6.0318.
5. Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM. Australian ovarian cancer study group and australian national endometrial cancer study group. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: An Australian case-control study. Can Caus Cont. 2010;21(12):2303-2308. doi: 10.1007/s10552-010-9658-7. Epub 2010 Oct 17.
6. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25. doi: https://doi.org/10.1016/j.fertnstert.2003.10.004.
7. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163-170.
8. McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: Implications for polycystic ovary syndrome. Semin Reprod Med. 2002;20(4):317-326.
9. Stubbs SA, Webber LJ, Stark J, Rice S, Margara R, Lavery S, et al. Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries. J Clin Endocrinol Metab. 2013;98(8):3298-3305. doi: 10.1210/jc.2013-1378. Epub 2013 Jun 7.
10. Bekx MT, Connor EC, Allen DB. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2010;23(1):7-10. doi: 10.1016/j.jpag.2009.04.004. Epub 2009 Aug 3.
11. Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci. 2009;2(1):12-17. doi: 10.4103/0974-1208.51336.
12. Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab. 2013;17(1):138-145. doi: 10.4103/2230-8210.107858.
13. Saxena P, Prakash A, Nigam A, Mishra A. Polycystic ovarian syndrome: Is obesity a sine qua non? A clinical, hormonal and metabolic assessment in relation to body mass index. Indian J Endocr Metbol. 2012;16(6):996-999. doi: 10.4103/2230-8210.103011.
14. Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metabol. 2005;90(8):4650-4658. doi: https://doi.org/10.1210/jc.2005-0628.
15. Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ. The Polycystic Ovary Syndrome health-related quality of life Questionnaire (PCOSQ): A validation. Hum Reprod. 2004;19(2):371-377. doi: https://doi.org/10.1093/humrep/deh048.
16. Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol. 2007;8(4):201-219. doi: https://doi.org/10.2165/00128071-200708040-00003.
17. Hartman R, Defelice T, Tzu J, Meehan S, Sanchez M. Acanthosis nigricans in the setting of niacin therapy. Dermatol Online J. 2011;17(10):11.
18. Singh GK, Sen D, Mulajker DS, Suresh MS. Acanthosis nigricans associated with transitional cell carcinoma of the urinary bladder. Indian J Dermatol. 2011;56(6):722-725. doi: 10.4103/0019-5154.91837.
19. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976;294(14):739-745. doi: 10.1056/NEJM197604012941401.
20. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Extensive clinical experience: Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2-6. doi: https://doi.org/10.1210/jc.2005-1457.
Copyright (c) 2019 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.
OAI - Open Archives Initiative
Therapoid
